Skip to main content
Top

Inflammation

Issue 5/2012

Content (17 Articles)

Toll-like Receptor-Induced Inflammatory Cytokines are Suppressed by Gain of Function or Overexpression of Gα i2 Protein

Pengfei Li, Richard R. Neubig, Basilia Zingarelli, Keith Borg, Perry V. Halushka, James A. Cook, Hongkuan Fan

Chemotactic and Immunoregulatory Properties of Bone Cells are Modulated by Endotoxin-Stimulated Lymphocytes

Hrvoje Cvija, Natasa Kovacic, Vedran Katavic, Sanja Ivcevic, Hector Leonardo Aguila, Ana Marusic, Danka Grcevic

Sulfated Derivative of 20(S)-Ginsenoside Rh2 Inhibits Inflammatory Cytokines Through MAPKs and NF-kappa B Pathways in LPS-Induced RAW264.7 Macrophages

Wen-Yan Bi, Ben-Dong Fu, Hai-Qing Shen, Qian Wei, Cui Zhang, Zhou Song, Qian-Qian Qin, Hui-Ping Li, Shuang Lv, Shuai-Cheng Wu, Peng-Fei Yi, Xu-Bin Wei

Stevioside Suppressed Inflammatory Cytokine Secretion by Downregulation of NF-κB and MAPK Signaling Pathways in LPS-Stimulated RAW264.7 Cells

Li Fengyang, Fu Yunhe, Liu Bo, Liu Zhicheng, Li Depeng, Liang Dejie, Zhang Wen, Cao Yongguo, Zhang Naisheng, Zhang Xichen, Yang Zhengtao

Role of PPARγ in COX-2 Activation in Mycobacterial Pulmonary Inflammation

Mari Kogiso, Tsutomu Shinohara, C. Kathleen Dorey, Yoshimi Shibata

Effect of Resveratrol on Treatment of Bleomycin-Induced Pulmonary Fibrosis in Rats

Recep Akgedik, Şükran Akgedik, Harun Karamanlı, Sema Uysal, Bülent Bozkurt, Duygu Ozol, Ferah Armutcu, Zeki Yıldırım

Relation Between C-Reactive Protein and Impaired Fasting Glucose in Obese Subjects

Luis E. Simental-Mendía, Brissia Lazalde, Graciela Zambrano-Galván, Luis Simental-Saucedo, Elizabeth Rábago-Sánchez, Martha Rodríguez-Morán, Fernando Guerrero-Romero

Prolidase Could Act as a Diagnosis and Treatment Mediator in Lung Fibrosis

Ibrahim Türkbeyler, Tuncer Demir, Yavuz Pehlivan, Davut Sinan Kaplan, Ali Osman Ceribasi, Mustafa Orkmez, Nurten Aksoy, Seyithan Taysi, Bunyamin Kisacik, Ahmet Mesut Onat

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.